Health Care insider trading activity
In the last 30 days, insiders at 347 Health Care companies reported 208 purchases worth $168.88M and 1,037 sales worth $1.60B. Below, the companies are ranked by how many insiders filed.
Most-active companies
200Showing companies 51 to 100 of 200 by distinct insiders filing.
Industries in this sector
10- Pharmaceutical Preparations - 152 companies
- Biological Products, (No Diagnostic Substances) - 63 companies
- Surgical & Medical Instruments & Apparatus - 44 companies
- Services-Medical Laboratories - 13 companies
- Electromedical & Electrotherapeutic Apparatus - 11 companies
- Services-Commercial Physical & Biological Research - 8 companies
- Orthopedic, Prosthetic & Surgical Appliances & Supplies - 8 companies
- Hospital & Medical Service Plans - 7 companies
- Laboratory Analytical Instruments - 6 companies
- In Vitro & In Vivo Diagnostic Substances - 6 companies
Reading a sector
Sales usually dwarf purchases, and that is normal, not a warning. Executives are paid in stock. They sell to diversify and to pay the tax due when awards vest, so a big sell total across a sector mostly reflects a vesting calendar. Purchases are the rarer side, because each one is an insider choosing to add to a company they already know well.
The table ranks companies by how many different insiders filed, not by dollars. That puts the cluster case near the top: several people inside one business acting in the same month. Sector placement comes from each company's SEC SIC code, mapped to the GICS sectors through a standard crosswalk, with manual fixes for well-known names the SIC code gets wrong. A single company can still land in a different sector than an index provider would give it.
